| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Iovance Biotherapeutics Inc. (LSE: 0JDK)
0JDK Technical Analysis
5
| As on 11th Jul 2023 0JDK STOCK Price closed @ 7.97 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 13.46 & Strong Sell for SHORT-TERM with Stoploss of 23.39 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0JDKSTOCK Price
| Open | 7.84 | Change | Price | % |
| High | 8.10 | 1 Day | -0.74 | -8.50 |
| Low | 7.70 | 1 Week | 0.84 | 11.78 |
| Close | 7.97 | 1 Month | -0.63 | -7.33 |
| Volume | 26775 | 1 Year | -15.82 | -66.50 |
| 52 Week High 27.04 | 52 Week Low 5.40 | ||||
LSE UK Most Active Stocks
| DKE | 0.15 | 0.00% |
| NNN | 0.09 | 50.00% |
| SYME | 0.10 | -9.09% |
| DMTR | 0.03 | 0.00% |
| PREM | 0.53 | 3.92% |
| MCLS | 1.68 | 46.09% |
| YGEN | 0.49 | 0.00% |
| CLON | 0.11 | 0.00% |
| VOD | 71.04 | 0.57% |
| BOIL | 0.10 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| 0JDK Daily Charts |
0JDK Intraday Charts |
Whats New @ Bazaartrend |
0JDK Free Analysis |
|
|
0JDK Important Levels Intraday
| RESISTANCE | 8.74 |
| RESISTANCE | 8.49 |
| RESISTANCE | 8.34 |
| RESISTANCE | 8.19 |
| SUPPORT | 7.75 |
| SUPPORT | 7.60 |
| SUPPORT | 7.45 |
| SUPPORT | 7.20 |
0JDK Forecast May 2024
| 4th UP Forecast | 17.59 |
| 3rd UP Forecast | 14.5 |
| 2nd UP Forecast | 12.6 |
| 1st UP Forecast | 10.69 |
| 1st DOWN Forecast | 5.25 |
| 2nd DOWN Forecast | 3.34 |
| 3rd DOWN Forecast | 1.44 |
| 4th DOWN Forecast | -1.65 |
0JDK Weekly Forecast
| 4th UP Forecast | 15.43 |
| 3rd UP Forecast | 13.04 |
| 2nd UP Forecast | 11.56 |
| 1st UP Forecast | 10.08 |
| 1st DOWN Forecast | 5.86 |
| 2nd DOWN Forecast | 4.38 |
| 3rd DOWN Forecast | 2.90 |
| 4th DOWN Forecast | 0.51 |
0JDK Forecast2024
| 4th UP Forecast | 50.46 |
| 3rd UP Forecast | 36.83 |
| 2nd UP Forecast | 28.41 |
| 1st UP Forecast | 19.99 |
| 1st DOWN Forecast | -4.05 |
| 2nd DOWN Forecast | -12.47 |
| 3rd DOWN Forecast | -20.89 |
| 4th DOWN Forecast | -34.52 |
Iovance Biotherapeutics Inc. ( LSE UK Symbol : 0JDK )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
0JDK Business Profile
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; and Novartis Pharma AG. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. Address: 999 Skyway Road, San Carlos, CA, United States, 94070
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service